MEP22508A - Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same - Google Patents
Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing sameInfo
- Publication number
- MEP22508A MEP22508A MEP-225/08A MEP22508A MEP22508A ME P22508 A MEP22508 A ME P22508A ME P22508 A MEP22508 A ME P22508A ME P22508 A MEP22508 A ME P22508A
- Authority
- ME
- Montenegro
- Prior art keywords
- alk
- nr5r6
- same
- fgfs
- inhibitors
- Prior art date
Links
- 125000003406 indolizinyl group Chemical class C=1(C=CN2C=CC=CC12)* 0.000 title 1
- 239000003112 inhibitor Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- -1 amino, carboxyl Chemical group 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 150000001350 alkyl halides Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204220A FR2838123B1 (fr) | 2002-04-04 | 2002-04-04 | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
| PCT/FR2003/001030 WO2003084956A1 (fr) | 2002-04-04 | 2003-04-02 | NOUVEAUX DERIVES D'INDOLIZINE 1,2,3 SUBSTITUEE, INHIBITEURS DES FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP22508A true MEP22508A (en) | 2010-06-10 |
Family
ID=28052118
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-225/08A MEP22508A (en) | 2002-04-04 | 2003-04-02 | Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| MEP-2008-225A ME00118B (me) | 2002-04-04 | 2003-04-02 | NOVI DERIVATI 1.2,3-SUPSTITUISANOG INDOLIZINA I iNHIBITORI FGFa, POSTUPCI ZA NJIHOVO DOBIJANJE I FARMACEUTSKI PREPARATI KOJI SADRŽE OVE DERIVATE |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-225A ME00118B (me) | 2002-04-04 | 2003-04-02 | NOVI DERIVATI 1.2,3-SUPSTITUISANOG INDOLIZINA I iNHIBITORI FGFa, POSTUPCI ZA NJIHOVO DOBIJANJE I FARMACEUTSKI PREPARATI KOJI SADRŽE OVE DERIVATE |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7442708B2 (sr) |
| EP (1) | EP1495023B1 (sr) |
| JP (1) | JP4741799B2 (sr) |
| KR (1) | KR101022138B1 (sr) |
| CN (1) | CN100413863C (sr) |
| AR (1) | AR040404A1 (sr) |
| AT (1) | ATE304013T1 (sr) |
| AU (1) | AU2003240984B2 (sr) |
| BR (1) | BR0309026A (sr) |
| CA (1) | CA2476056C (sr) |
| CO (1) | CO5631442A2 (sr) |
| DE (1) | DE60301570T2 (sr) |
| DK (1) | DK1495023T3 (sr) |
| EA (1) | EA007902B1 (sr) |
| EC (1) | ECSP045338A (sr) |
| ES (1) | ES2247540T3 (sr) |
| FR (1) | FR2838123B1 (sr) |
| HR (1) | HRP20040912B1 (sr) |
| IL (2) | IL163755A0 (sr) |
| IS (1) | IS2475B (sr) |
| MA (1) | MA27297A1 (sr) |
| ME (2) | MEP22508A (sr) |
| MX (1) | MXPA04009639A (sr) |
| NO (1) | NO329025B1 (sr) |
| NZ (1) | NZ534786A (sr) |
| PL (1) | PL215265B1 (sr) |
| RS (1) | RS51399B (sr) |
| SI (1) | SI1495023T1 (sr) |
| TN (1) | TNSN04188A1 (sr) |
| TW (1) | TWI335222B (sr) |
| UA (1) | UA78016C2 (sr) |
| WO (1) | WO2003084956A1 (sr) |
| ZA (1) | ZA200406613B (sr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| WO2005042737A1 (ja) * | 2003-11-04 | 2005-05-12 | Dnavec Research Inc. | 遺伝子導入された樹状細胞の製造方法 |
| FR2865934B1 (fr) | 2004-02-05 | 2006-05-05 | Sanofi Synthelabo | Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne |
| WO2006001120A1 (ja) * | 2004-06-24 | 2006-01-05 | Dnavec Research Inc. | マイナス鎖rnaウイルスを含む抗癌剤 |
| MX2007006102A (es) * | 2004-11-22 | 2007-07-11 | Threshold Pharmaceuticals Inc | Agentes anti-cancer de union a tubulina y profarmacos de los mismos. |
| FR2883286B1 (fr) * | 2005-03-16 | 2008-10-03 | Sanofi Aventis Sa | NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
| FR2896247B1 (fr) * | 2006-01-13 | 2008-02-29 | Sanofi Aventis Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
| EP1891955A1 (en) * | 2006-07-24 | 2008-02-27 | Sanofi-Aventis | Use of 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, for the preparation of a medicament intended for the treatment of degenerative joint diseases |
| WO2010027762A1 (en) * | 2008-09-04 | 2010-03-11 | Boehringer Ingelheim International Gmbh | Indolizine inhibitors of leukotriene production |
| WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
| EP2270043A1 (en) * | 2009-07-03 | 2011-01-05 | Sanofi-Aventis | Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
| CN101648953B (zh) * | 2009-09-24 | 2012-09-05 | 绍兴文理学院 | 一种咪唑并[1，2-b]吡咯并[1，2-f]哒嗪衍生物及其制备方法和用途 |
| FR2962438B1 (fr) * | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
| FR2962437B1 (fr) * | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
| FR2967412B1 (fr) * | 2010-11-17 | 2012-12-14 | Sanofi Aventis | Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique |
| FR2985258A1 (fr) * | 2011-12-28 | 2013-07-05 | Sanofi Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
| MX385021B (es) * | 2014-12-10 | 2025-03-14 | Ono Pharmaceutical Co | Derivado de dihidroindolizinona. |
| EP3318563A1 (en) * | 2016-11-07 | 2018-05-09 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
| CN108864083B (zh) * | 2018-06-07 | 2021-05-25 | 广东药科大学 | 一类具有抗癌活性的氨基取代吲嗪类化合物及其衍生物 |
| CN110251513A (zh) * | 2019-07-03 | 2019-09-20 | 南京大学 | 一种含吡唑的中氮茚化合物在制备抗肿瘤药物中的应用 |
| US11976066B1 (en) | 2023-10-23 | 2024-05-07 | King Faisal University | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ193926A (en) * | 1979-07-06 | 1984-05-31 | Labaz Sanofi Nv | 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines |
| US4378362A (en) * | 1979-12-06 | 1983-03-29 | S.A. Labaz N.V. | Indolizine derivatives and process for preparing the same |
| FR2528845A1 (fr) * | 1982-06-17 | 1983-12-23 | Sanofi Sa | Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant |
| FR2594438B1 (fr) * | 1986-02-14 | 1990-01-26 | Labaz Sanofi Nv | Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant |
| GB9318790D0 (en) * | 1993-09-10 | 1993-10-27 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
| DE60026297T2 (de) * | 1999-05-21 | 2006-11-02 | Bristol-Myers Squibb Co. | Pyrrolotriazin kinasehemmer |
| EP1399442B1 (en) * | 2001-06-06 | 2006-08-09 | Vertex Pharmaceuticals Incorporated | Cak inhibitors and uses thereof |
| FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
-
2002
- 2002-04-04 FR FR0204220A patent/FR2838123B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-04 UA UA20040807138A patent/UA78016C2/uk unknown
- 2003-03-27 TW TW092106944A patent/TWI335222B/zh not_active IP Right Cessation
- 2003-04-02 ZA ZA200406613A patent/ZA200406613B/en unknown
- 2003-04-02 IL IL16375503A patent/IL163755A0/xx unknown
- 2003-04-02 CN CNB038077361A patent/CN100413863C/zh not_active Expired - Lifetime
- 2003-04-02 SI SI200330093T patent/SI1495023T1/sl unknown
- 2003-04-02 PL PL372812A patent/PL215265B1/pl unknown
- 2003-04-02 MX MXPA04009639A patent/MXPA04009639A/es active IP Right Grant
- 2003-04-02 RS YUP-864/04A patent/RS51399B/sr unknown
- 2003-04-02 DE DE60301570T patent/DE60301570T2/de not_active Expired - Lifetime
- 2003-04-02 NZ NZ534786A patent/NZ534786A/en not_active IP Right Cessation
- 2003-04-02 AU AU2003240984A patent/AU2003240984B2/en not_active Expired
- 2003-04-02 US US10/509,919 patent/US7442708B2/en not_active Expired - Lifetime
- 2003-04-02 CA CA2476056A patent/CA2476056C/fr not_active Expired - Lifetime
- 2003-04-02 ES ES03730302T patent/ES2247540T3/es not_active Expired - Lifetime
- 2003-04-02 ME MEP-225/08A patent/MEP22508A/xx unknown
- 2003-04-02 WO PCT/FR2003/001030 patent/WO2003084956A1/fr not_active Ceased
- 2003-04-02 BR BR0309026-4A patent/BR0309026A/pt not_active IP Right Cessation
- 2003-04-02 AR AR20030101142A patent/AR040404A1/es active IP Right Grant
- 2003-04-02 AT AT03730302T patent/ATE304013T1/de active
- 2003-04-02 ME MEP-2008-225A patent/ME00118B/me unknown
- 2003-04-02 JP JP2003582153A patent/JP4741799B2/ja not_active Expired - Lifetime
- 2003-04-02 HR HRP20040912AA patent/HRP20040912B1/hr not_active IP Right Cessation
- 2003-04-02 EP EP03730302A patent/EP1495023B1/fr not_active Expired - Lifetime
- 2003-04-02 EA EA200400994A patent/EA007902B1/ru not_active IP Right Cessation
- 2003-04-02 DK DK03730302T patent/DK1495023T3/da active
- 2003-04-02 KR KR1020047015666A patent/KR101022138B1/ko not_active Expired - Fee Related
-
2004
- 2004-08-19 IS IS7413A patent/IS2475B/is unknown
- 2004-08-26 IL IL163755A patent/IL163755A/en not_active IP Right Cessation
- 2004-09-27 MA MA27876A patent/MA27297A1/fr unknown
- 2004-09-30 TN TNP2004000188A patent/TNSN04188A1/fr unknown
- 2004-09-30 NO NO20044156A patent/NO329025B1/no not_active IP Right Cessation
- 2004-10-01 CO CO04098197A patent/CO5631442A2/es not_active Application Discontinuation
- 2004-10-04 EC EC2004005338A patent/ECSP045338A/es unknown
-
2008
- 2008-08-26 US US12/198,545 patent/US7803811B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP22508A (en) | Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| AR030959A1 (es) | Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen | |
| AR037676A1 (es) | Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulacion; composicion farmaceutica que los comprende y procedimiento para preparar compuestos de formula (i) | |
| GEP20074148B (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
| CO5690588A2 (es) | Derivados de 4-tetrazolilo-4 fenilpiperidina para el trata- miento del dolor | |
| AR003453A1 (es) | Inhibidores de agregado de plaquetas, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene y procedimiento para la preparacion de dichos inhibidores | |
| HRP20060100T3 (en) | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | |
| HRP20080120T3 (hr) | Spojevi i postupci za inhibiciju napredovanja mitoze s pomoću inhibicije aurora kinaze | |
| RU2005116254A (ru) | Производные пиридопирролизина и пиридоиндолизина | |
| SE9702799D0 (sv) | New compounds | |
| AR042024A1 (es) | Compuestos farmaceuticos derivados de piridona, pirimidona y pirazinona | |
| AR043674A1 (es) | Derivados de piridazinona como inhibidores no nucleosidos de la transcriptasa reversa | |
| PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
| AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| CO5011090A1 (es) | Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos | |
| SE0101579D0 (sv) | New compounds | |
| AR048042A1 (es) | Inhibidores no nucleosidos de transcriptasa inversa y composiciones farmaceuticas | |
| RU2409572C2 (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний | |
| AR019409A1 (es) | Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados | |
| DE69630160D1 (de) | Selektive Thrombin-Hemmer | |
| SE9703377D0 (sv) | New compounds | |
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| AR061835A1 (es) | Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| TW200519113A (en) | Novel 1, 2, 3, 6, 7, 8-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them |